Status:
RECRUITING
ITP Registry and Accompanying Biospecimen Collection
Lead Sponsor:
Jena University Hospital
Collaborating Sponsors:
University Hospital Dresden
Novartis
Conditions:
Immune Thrombocytopenia
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
Detailed Description
Immune thrombocytopenia (ITP) is a rare hematologic disorder that can lead to a greater risk of bleeding or a prolonged bleeding time due to an autoimmune-mediated deficiency of platelets. In recent ...
Eligibility Criteria
Inclusion Criteria:
- Primary or secondary Immune Thrombocytopenia (ITP)
- Age ≥18 years
- signed declaration of consent
Exclusion Criteria:
- diagnoses that cannot be reconciled with the diagnosis of ITP (esp. heparin-induced thrombocytopenia, pregnancy-associated thrombocytopenia, pseudothrombocytopenia)
- no informed consent possible (this covers patients who are unable to understand the nature and scope of participation)
Key Trial Info
Start Date :
November 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT05152238
Start Date
November 29 2021
End Date
April 1 2027
Last Update
July 15 2025
Active Locations (64)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Aachen AöR
Aachen, Germany, 52074
2
Klinikum Altenburger Land GmbH, Klinik für Innere Medizin/Hämatologie/Onkologie
Altenburg, Germany, 04600
3
MVZ am Klinikum Aschaffenburg
Aschaffenburg, Germany, 63739
4
MVZ IMD GmbH, IMD Gerinnungszentrum Hochtaunus
Bad Homburg, Germany, 61352